Newsletter | March 16, 2026

03.16.26 -- Struggling with mAb aggregation and other impurities?

Optimizing Antibody Variant Capture: Strategies To Combat Aggregation, Impurities, And Low Yields

Watch the webinar to learn how to avoid acid-induced aggregation in pH sensitive antibodies with MabSelect™ mild elution protein A resin.

 

Level Up Your Knowledge Of Purification Of Antibody-Derived Molecules

Access courses to enhance your understanding of mAbs and their variants, enabling more effective purification strategies in therapeutic development.

 

Host Cell Protein (HCP) Removal Post Virus Inactivation In mAb Processing

HCPs have the potential to affect product quality, safety, and efficacy. See our latest application work where we remove more than 90% HCPs using a positively charged depth filter post virus inactivation.

 

Comparing Process Development Approaches For Recombinant Proteins

See how Cytiva™ Protein Select™ technology enables faster chromatography process development and higher-purity protein in fewer steps compared to conventional methods.

 

Developing A HIC Polishing Step For The Removal Of mAb Aggregates

Learn in-depth about the development of a flow-through polishing step that employs hydrophobic interaction chromatography for the elimination of monoclonal antibody aggregates.

 

UPCOMING WEBINAR

 

 

 

Cytiva, MabSelect, and Protein Select are trademarks of Global Life Sciences Solutions USA LLC or an affiliate doing business as Cytiva.